Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Preface.

Politis M.

Int Rev Neurobiol. 2018;142:xi-xii. doi: 10.1016/S0074-7742(18)30146-6. No abstract available.

PMID:
30409262
2.

Structural Magnetic Resonance Imaging in Huntington's Disease.

Wilson H, Dervenoulas G, Politis M.

Int Rev Neurobiol. 2018;142:335-380. doi: 10.1016/bs.irn.2018.09.006. Epub 2018 Oct 8.

PMID:
30409258
3.

Molecular Imaging in Huntington's Disease.

Wilson H, Politis M.

Int Rev Neurobiol. 2018;142:289-333. doi: 10.1016/bs.irn.2018.08.007. Epub 2018 Aug 29.

PMID:
30409256
4.

PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.

Niccolini F, Mencacci NE, Yousaf T, Rabiner EA, Salpietro V, Pagano G, Balint B, Efthymiou S, Houlden H, Gunn RN, Wood N, Bhatia KP, Politis M.

Mov Disord. 2018 Oct 21. doi: 10.1002/mds.27523. [Epub ahead of print]

PMID:
30345538
5.

Neuroimaging of Sleep Disturbances in Movement Disorders.

Yousaf T, Pagano G, Wilson H, Politis M.

Front Neurol. 2018 Sep 11;9:767. doi: 10.3389/fneur.2018.00767. eCollection 2018. Review.

6.

Preface.

Politis M.

Int Rev Neurobiol. 2018;141:xv-xvi. doi: 10.1016/S0074-7742(18)30122-3. No abstract available.

PMID:
30314609
7.

Advances in MRI Methodology.

Yousaf T, Dervenoulas G, Politis M.

Int Rev Neurobiol. 2018;141:31-76. doi: 10.1016/bs.irn.2018.08.008. Epub 2018 Sep 14.

PMID:
30314602
8.

Molecular Imaging of the Serotonergic System in Parkinson's Disease.

Pagano G, Politis M.

Int Rev Neurobiol. 2018;141:173-210. doi: 10.1016/bs.irn.2018.08.002. Epub 2018 Sep 6.

PMID:
30314596
9.

Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.

de Natale ER, Niccolini F, Wilson H, Politis M.

Int Rev Neurobiol. 2018;141:131-172. doi: 10.1016/bs.irn.2018.08.003. Epub 2018 Sep 6.

PMID:
30314595
10.

Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.

Chandra A, Dervenoulas G, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol. 2018 Aug 17. doi: 10.1007/s00415-018-9016-3. [Epub ahead of print] Review.

PMID:
30120563
11.

Disease-related patterns of in vivo pathology in Corticobasal syndrome.

Niccolini F, Wilson H, Hirschbichler S, Yousaf T, Pagano G, Whittington A, Caminiti SP, Erro R, Holton JL, Jaunmuktane Z, Esposito M, Martino D, Abdul A, Passchier J, Rabiner EA, Gunn RN, Bhatia KP, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2413-2425. doi: 10.1007/s00259-018-4104-2. Epub 2018 Aug 8.

12.

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.

Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M.

Neurology. 2018 Sep 4;91(10):e894-e905. doi: 10.1212/WNL.0000000000006134. Epub 2018 Aug 8.

PMID:
30089615
13.

Proton Collision on Deoxyribose Originating from Doubly Ionized Water Molecule Dissociation.

Hervé du Penhoat MA, Moraga NRG, Gaigeot MP, Vuilleumier R, Tavernelli I, Politis MF.

J Phys Chem A. 2018 Jun 21;122(24):5311-5320. doi: 10.1021/acs.jpca.8b04787. Epub 2018 Jun 11.

PMID:
29846073
14.

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.

Wilson H, Giordano B, Turkheimer FE, Chaudhuri KR, Politis M.

Neuroimage Clin. 2018 Mar 2;18:630-637. doi: 10.1016/j.nicl.2018.03.001. eCollection 2018.

15.

Neuroimaging in Lewy body dementia.

Yousaf T, Dervenoulas G, Valkimadi PE, Politis M.

J Neurol. 2018 May 14. doi: 10.1007/s00415-018-8892-x. [Epub ahead of print] Review.

PMID:
29761296
16.

Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.

Schulz J, Pagano G, Fernández Bonfante JA, Wilson H, Politis M.

Brain. 2018 May 1;141(5):1501-1516. doi: 10.1093/brain/awy072.

17.

Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.

Nørgaard M, Ganz M, Svarer C, Feng L, Ichise M, Lanzenberger R, Lubberink M, Parsey RV, Politis M, Rabiner EA, Slifstein M, Sossi V, Suhara T, Talbot PS, Turkheimer F, Strother SC, Knudsen GM.

J Cereb Blood Flow Metab. 2018 Apr 13:271678X18770107. doi: 10.1177/0271678X18770107. [Epub ahead of print]

PMID:
29651896
18.

Diabetes mellitus and Parkinson disease.

Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, Politis M.

Neurology. 2018 May 8;90(19):e1654-e1662. doi: 10.1212/WNL.0000000000005475. Epub 2018 Apr 6.

PMID:
29626177
19.

Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.

Yousaf T, Pagano G, Niccolini F, Politis M.

J Neurol Sci. 2018 Apr 15;387:220-227. doi: 10.1016/j.jns.2018.02.032. Epub 2018 Feb 21.

PMID:
29571867
20.

Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness.

Yousaf T, Pagano G, Niccolini F, Politis M.

Sleep Med. 2018 Mar;43:25-30. doi: 10.1016/j.sleep.2017.11.1137. Epub 2017 Dec 12.

PMID:
29482807
21.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
22.

Roles of Hydration for Inducing Decomposition of 2-Deoxy-d-ribose by Ionization of Oxygen K-Shell Electrons.

Fujii K, Izumi Y, Narita A, Ghose KK, López-Tarifa P, Touati A, Spezia R, Vuilleumier R, Gaigeot MP, Politis MF, Du Penhoat MH, Yokoya A.

Radiat Res. 2018 Mar;189(3):264-272. doi: 10.1667/RR14225.1. Epub 2018 Jan 8.

PMID:
29309265
23.

The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies.

Pagano G, Niccolini F, Politis M.

J Neural Transm (Vienna). 2018 Aug;125(8):1217-1223. doi: 10.1007/s00702-017-1823-7. Epub 2017 Dec 20. Review.

24.

Be vigilant for dementia in Parkinson’s disease.

Niccolini F, Diamantopoulos K, Kiosses S, Politis M.

Practitioner. 2017 May;261(1804):11-5. Review.

PMID:
29120562
25.

11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.

Li W, Lao-Kaim NP, Roussakis AA, Martín-Bastida A, Valle-Guzman N, Paul G, Loane C, Widner H, Politis M, Foltynie T, Barker RA, Piccini P.

Mov Disord. 2018 Jan;33(1):117-127. doi: 10.1002/mds.27183. Epub 2017 Oct 30.

PMID:
29082547
26.

Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.

Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M.

Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.

PMID:
29078029
27.

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.

Pagano G, Yousaf T, Politis M.

Curr Neurol Neurosci Rep. 2017 Oct 3;17(11):90. doi: 10.1007/s11910-017-0794-2. Review.

28.

Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies.

Niccolini F, Pagano G, Fusar-Poli P, Wood A, Mrzljak L, Sampaio C, Politis M.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):185-196. doi: 10.1136/jnnp-2017-316633. Epub 2017 Sep 9. Review.

PMID:
28889093
29.

Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients.

Politis M, Wilson H, Wu K, Brooks DJ, Piccini P.

Neuroimage Clin. 2017 Aug 24;16:455-460. doi: 10.1016/j.nicl.2017.08.013. eCollection 2017.

30.

Imaging the Nonmotor Symptoms in Parkinson's Disease.

Yousaf T, Wilson H, Politis M.

Int Rev Neurobiol. 2017;133:179-257. doi: 10.1016/bs.irn.2017.05.001. Epub 2017 Jun 7. Review.

PMID:
28802921
31.

Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer's disease.

Moonga I, Niccolini F, Wilson H, Pagano G, Politis M; Alzheimer's Disease Neuroimaging Initiative.

Eur J Neurol. 2017 Sep;24(9):1173-1182. doi: 10.1111/ene.13374. Epub 2017 Jul 28.

PMID:
28752644
32.

Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.

Niccolini F, Wilson H, Pagano G, Coello C, Mehta MA, Searle GE, Gunn RN, Rabiner EA, Foltynie T, Politis M.

Neurology. 2017 Aug 8;89(6):586-593. doi: 10.1212/WNL.0000000000004201. Epub 2017 Jul 12.

PMID:
28701494
33.

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Qamar MA, Sauerbier A, Politis M, Carr H, Loehrer P, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Jan 25;3:5. doi: 10.1038/s41531-016-0006-9. eCollection 2017.

34.

PET image reconstruction using multi-parametric anato-functional priors.

Mehranian A, Belzunce MA, Niccolini F, Politis M, Prieto C, Turkheimer F, Hammers A, Reader AJ.

Phys Med Biol. 2017 Jul 6;62(15):5975-6007. doi: 10.1088/1361-6560/aa7670.

PMID:
28570263
35.

Imaging in Parkinson's Disease.

Politis M, Pagano G, Niccolini F.

Int Rev Neurobiol. 2017;132:233-274. doi: 10.1016/bs.irn.2017.02.015. Epub 2017 Mar 30. Review.

PMID:
28554409
36.

Disease progression in LRRK2 parkinsonism.

Politis M.

Lancet Neurol. 2017 May;16(5):334-335. doi: 10.1016/S1474-4422(17)30082-0. No abstract available.

PMID:
28414642
37.

It is a painful somatic symptom, not the history of cancer/malignancy that is associated with depression: findings from multiple national surveys.

Johnson K, Politis MD, Hansen AR, McKenzie LE, Duncan DT, Zhang J.

Pain. 2017 Apr;158(4):740-746. doi: 10.1097/j.pain.0000000000000826.

PMID:
28301860
38.

Cognitive decline in Parkinson disease.

Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C.

Nat Rev Neurol. 2017 Apr;13(4):217-231. doi: 10.1038/nrneurol.2017.27. Epub 2017 Mar 3. Review.

39.

Urinary dysfunction in early de novo patients with Parkinson's disease.

Pagano G, Niccolini F, Yousaf T, Wilson H, Polychronis S, Chaudhuri KR, Politis M.

Mov Disord. 2017 Jun;32(6):939-940. doi: 10.1002/mds.26967. Epub 2017 Mar 3. No abstract available.

PMID:
28256013
40.

Molecular Imaging Markers to Track Huntington's Disease Pathology.

Wilson H, De Micco R, Niccolini F, Politis M.

Front Neurol. 2017 Jan 30;8:11. doi: 10.3389/fneur.2017.00011. eCollection 2017. Review.

41.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group.

Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Review.

PMID:
28150432
42.

Gender-based differences in water, sanitation and hygiene-related diarrheal disease and helminthic infections: a systematic review and meta-analysis.

Sevilimedu V, Pressley KD, Snook KR, Hogges JV, Politis MD, Sexton JK, Duke CH, Smith BA, Swander LC, Baker KK, Gambhir M, Fung IC.

Trans R Soc Trop Med Hyg. 2017 Jan 22. doi: 10.1093/trstmh/trw080. [Epub ahead of print] Review.

PMID:
28115686
43.

The psychosis spectrum in Parkinson disease.

Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D.

Nat Rev Neurol. 2017 Feb;13(2):81-95. doi: 10.1038/nrneurol.2016.200. Epub 2017 Jan 20. Review.

44.

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism (Niccolini and Politis, 2016) : Reply to Jean-Claude Baron Letter to Editor.

Politis M.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):548-550. doi: 10.1007/s00259-016-3597-9. No abstract available.

PMID:
28025656
45.

Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies.

Pagano G, Niccolini F, Fusar-Poli P, Politis M.

Ann Neurol. 2017 Feb;81(2):171-180. doi: 10.1002/ana.24859. Review.

PMID:
28019672
46.

Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.

Martin-Bastida A, Lao-Kaim NP, Loane C, Politis M, Roussakis AA, Valle-Guzman N, Kefalopoulou Z, Paul-Visse G, Widner H, Xing Y, Schwarz ST, Auer DP, Foltynie T, Barker RA, Piccini P.

Eur J Neurol. 2017 Feb;24(2):357-365. doi: 10.1111/ene.13208. Epub 2016 Dec 16.

47.

Corrigendum to "Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers" [Neurobiol. Dis. 83 (2015) 115-121].

Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P.

Neurobiol Dis. 2017 Feb;98:162. doi: 10.1016/j.nbd.2016.12.003. Epub 2016 Dec 8. No abstract available.

PMID:
27939917
48.

Trends of Bacterial Keratitis Culture Isolates in Jerusalem; a 13- Years Analysis.

Politis M, Wajnsztajn D, Rosin B, Block C, Solomon A.

PLoS One. 2016 Nov 28;11(11):e0165223. doi: 10.1371/journal.pone.0165223. eCollection 2016.

49.

Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients.

Politis M, Sauerbier A, Loane C, Pavese N, Martin A, Corcoran B, Brooks DJ, Ray-Chaudhuri K, Piccini P.

Mov Disord. 2017 Feb;32(2):235-240. doi: 10.1002/mds.26848. Epub 2016 Nov 17.

PMID:
27859651
50.

Ocular Siderosis Subsequent to a Missed Pars Plana Metallic Foreign Body that Masqueraded as Refractory Intermediate Uveitis.

Politis M, Rosin B, Amer R.

Ocul Immunol Inflamm. 2018;26(4):598-600. doi: 10.1080/09273948.2016.1240206. Epub 2016 Nov 16. No abstract available.

PMID:
27849408

Supplemental Content

Loading ...
Support Center